Parker Burrows, Ruth-Ann Brown, Abigail Samuelsen, Anthony S Bonavia
{"title":"危重病人住院抗生素使用与长期预后的关系","authors":"Parker Burrows, Ruth-Ann Brown, Abigail Samuelsen, Anthony S Bonavia","doi":"10.1017/ash.2025.10054","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess whether antibiotic duration (AD) and one-year antibiotic-free days (AFD) are associated with key in-hospital and post-discharge outcomes among critically ill adults.</p><p><strong>Design: </strong>Prospective observational study.</p><p><strong>Setting: </strong>611-bed, quaternary care academic medical center in the United States.</p><p><strong>Patients: </strong>126 critically ill adults (mean age 68.1 ± 15.6 yr, 51.6% male, median APACHE II score 20.5 [IQR 15-25]); 71.4% met sepsis criteria.</p><p><strong>Methods: </strong>Secondary infection was defined as ≥3 consecutive antibiotic days within a year after the index sepsis admission. Multivariate analyses adjusted for age, APACHE II score, BMI, and glucocorticosteroid dose. Time-to-event analysis employed Cox proportional hazards modeling; cumulative infection burden was assessed via nonparametric tests using normalized antibiotic exposure (AD as a proportion of days alive).</p><p><strong>Results: </strong>Within 30 days, longer AD correlated with increased hospital stay; each additional antibiotic day added ∼0.93 hospital days (<i>P</i> < 0.001) in adjusted linear regression. AD did not predict one-year mortality (OR 1.01, <i>P</i> = 0.739) or readmission (OR 1.01, <i>P</i> = 0.771). Normalized antibiotic exposure significantly differed by cumulative secondary infection episodes (<i>P</i> = 0.0033), with higher exposure among patients experiencing two or more secondary infections (<i>P</i> = 0.026 and <i>P</i> = 0.036, respectively). Cox regression showed a significant association between AD and time to first secondary infection (HR 1.10, 95% CI: 1.04-1.15, <i>P</i> = 0.001), indicating that longer AD predisposed to secondary infection or recurrent antibiotic use.</p><p><strong>Conclusions: </strong>Extended AD, in critically ill patients, prolongs hospitalization without reducing mortality or readmission rates. These findings highlight the importance of robust antibiotic stewardship practices, where shorter, targeted regimens may minimize unintended complications.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"5 1","pages":"e135"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188279/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association between in-hospital antibiotic use and long-term outcomes in critically ill patients.\",\"authors\":\"Parker Burrows, Ruth-Ann Brown, Abigail Samuelsen, Anthony S Bonavia\",\"doi\":\"10.1017/ash.2025.10054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To assess whether antibiotic duration (AD) and one-year antibiotic-free days (AFD) are associated with key in-hospital and post-discharge outcomes among critically ill adults.</p><p><strong>Design: </strong>Prospective observational study.</p><p><strong>Setting: </strong>611-bed, quaternary care academic medical center in the United States.</p><p><strong>Patients: </strong>126 critically ill adults (mean age 68.1 ± 15.6 yr, 51.6% male, median APACHE II score 20.5 [IQR 15-25]); 71.4% met sepsis criteria.</p><p><strong>Methods: </strong>Secondary infection was defined as ≥3 consecutive antibiotic days within a year after the index sepsis admission. Multivariate analyses adjusted for age, APACHE II score, BMI, and glucocorticosteroid dose. Time-to-event analysis employed Cox proportional hazards modeling; cumulative infection burden was assessed via nonparametric tests using normalized antibiotic exposure (AD as a proportion of days alive).</p><p><strong>Results: </strong>Within 30 days, longer AD correlated with increased hospital stay; each additional antibiotic day added ∼0.93 hospital days (<i>P</i> < 0.001) in adjusted linear regression. AD did not predict one-year mortality (OR 1.01, <i>P</i> = 0.739) or readmission (OR 1.01, <i>P</i> = 0.771). Normalized antibiotic exposure significantly differed by cumulative secondary infection episodes (<i>P</i> = 0.0033), with higher exposure among patients experiencing two or more secondary infections (<i>P</i> = 0.026 and <i>P</i> = 0.036, respectively). Cox regression showed a significant association between AD and time to first secondary infection (HR 1.10, 95% CI: 1.04-1.15, <i>P</i> = 0.001), indicating that longer AD predisposed to secondary infection or recurrent antibiotic use.</p><p><strong>Conclusions: </strong>Extended AD, in critically ill patients, prolongs hospitalization without reducing mortality or readmission rates. These findings highlight the importance of robust antibiotic stewardship practices, where shorter, targeted regimens may minimize unintended complications.</p>\",\"PeriodicalId\":72246,\"journal\":{\"name\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"volume\":\"5 1\",\"pages\":\"e135\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188279/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/ash.2025.10054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial stewardship & healthcare epidemiology : ASHE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/ash.2025.10054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:评估危重成人患者的抗生素持续时间(AD)和1年无抗生素天数(AFD)是否与关键的住院和出院后结局相关。设计:前瞻性观察研究。环境:611个床位,美国四级护理学术医疗中心。患者:重症成人126例(平均年龄68.1±15.6岁,男性51.6%,中位APACHEⅱ评分20.5 [IQR 15-25]);71.4%符合败血症标准。方法:继发感染定义为指标败血症入院后一年内连续使用抗生素天数≥3天。多变量分析调整了年龄、APACHE II评分、BMI和糖皮质激素剂量。时间-事件分析采用Cox比例风险模型;累积感染负担通过使用标准化抗生素暴露(AD占存活天数的比例)的非参数测试进行评估。结果:30天内AD时间越长,住院时间越长;调整后线性回归显示,每增加一个抗生素日,就增加约0.93个住院日(P < 0.001)。AD不能预测1年死亡率(OR 1.01, P = 0.739)或再入院率(OR 1.01, P = 0.771)。正常抗生素暴露量因继发感染的累积次数而显著不同(P = 0.0033),两次或两次以上继发感染的患者暴露量更高(P = 0.026和P = 0.036分别)。Cox回归显示,AD与首次继发感染时间之间存在显著相关性(HR 1.10, 95% CI: 1.04-1.15, P = 0.001),表明AD时间越长,继发感染或反复使用抗生素的可能性越大。结论:在危重症患者中,延长AD会延长住院时间,但不会降低死亡率或再入院率。这些发现强调了强有力的抗生素管理实践的重要性,其中较短的有针对性的方案可以最大限度地减少意外并发症。
Association between in-hospital antibiotic use and long-term outcomes in critically ill patients.
Objective: To assess whether antibiotic duration (AD) and one-year antibiotic-free days (AFD) are associated with key in-hospital and post-discharge outcomes among critically ill adults.
Design: Prospective observational study.
Setting: 611-bed, quaternary care academic medical center in the United States.
Patients: 126 critically ill adults (mean age 68.1 ± 15.6 yr, 51.6% male, median APACHE II score 20.5 [IQR 15-25]); 71.4% met sepsis criteria.
Methods: Secondary infection was defined as ≥3 consecutive antibiotic days within a year after the index sepsis admission. Multivariate analyses adjusted for age, APACHE II score, BMI, and glucocorticosteroid dose. Time-to-event analysis employed Cox proportional hazards modeling; cumulative infection burden was assessed via nonparametric tests using normalized antibiotic exposure (AD as a proportion of days alive).
Results: Within 30 days, longer AD correlated with increased hospital stay; each additional antibiotic day added ∼0.93 hospital days (P < 0.001) in adjusted linear regression. AD did not predict one-year mortality (OR 1.01, P = 0.739) or readmission (OR 1.01, P = 0.771). Normalized antibiotic exposure significantly differed by cumulative secondary infection episodes (P = 0.0033), with higher exposure among patients experiencing two or more secondary infections (P = 0.026 and P = 0.036, respectively). Cox regression showed a significant association between AD and time to first secondary infection (HR 1.10, 95% CI: 1.04-1.15, P = 0.001), indicating that longer AD predisposed to secondary infection or recurrent antibiotic use.
Conclusions: Extended AD, in critically ill patients, prolongs hospitalization without reducing mortality or readmission rates. These findings highlight the importance of robust antibiotic stewardship practices, where shorter, targeted regimens may minimize unintended complications.